(Q34148058)

31 July 2017

1 reference

title

Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard? (English)

1 reference

31 July 2017

0 references

Teri Pearlstein

1

1 reference

31 July 2017

publication date

1 January 2002

1 reference

31 July 2017

1 reference

31 July 2017

volume

62

1 reference

31 July 2017

issue

13

1 reference

31 July 2017

page(s)

1869-1885

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200262130-00004

31 July 2017

exact match

0 references

cites work

Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders.

1 reference

12 December 2020

Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes

1 reference

12 December 2020

Micronutrients and the premenstrual syndrome: the case for calcium

1 reference

12 December 2020

Effect of nutrient intake on premenstrual depression.

1 reference

12 December 2020

Long-term fluoxetine treatment of late luteal phase dysphoric disorder.

1 reference

12 December 2020

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

1 reference

12 December 2020

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

1 reference

12 December 2020

Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.

1 reference

12 December 2020

Fluvoxamine in the treatment of menstrually related mood disorders.

1 reference

12 December 2020

Assessing psychiatric impairment in primary care with the Sheehan Disability Scale

1 reference

12 December 2020

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome

1 reference

12 December 2020

Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.

1 reference

12 December 2020

Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome

1 reference

12 December 2020

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial

1 reference

12 December 2020

Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial

1 reference

12 December 2020

The measurement of premenstrual mood symptoms

1 reference

12 December 2020

Predictors of response to sertraline treatment of severe premenstrual syndromes.

1 reference

12 December 2020

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial

1 reference

12 December 2020

A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment.

1 reference

12 December 2020

Psychobiology of premenstrual dysphoric disorder

1 reference

12 December 2020

Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

Premenstrual changes: patterns and correlates of daily ratings

1 reference

12 December 2020

Fluvoxamine for premenstrual dysphoric disorder: a pilot study.

1 reference

12 December 2020

Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales

1 reference

12 December 2020

Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences.

1 reference

12 December 2020

Non-antidepressant treatment of premenstrual syndrome.

1 reference

12 December 2020

The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form.

1 reference

12 December 2020

Prospective assessment of menstrually related mood disorders

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual syndrome

1 reference

12 December 2020

The Arizona Sexual Experience Scale (ASEX): reliability and validity

1 reference

12 December 2020

Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant

1 reference

12 December 2020

Treatment of premenstrual syndrome with fluoxetine: an open study

1 reference

12 December 2020

Increased premenstrual dosing of nefazodone relieves premenstrual magnification of depression

1 reference

12 December 2020

A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.

1 reference

12 December 2020

Compliance to antidepressant drug therapy for treatment of premenstrual syndrome

1 reference

12 December 2020

Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.

1 reference

12 December 2020

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community

1 reference

12 December 2020

The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome

1 reference

12 December 2020

Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

12 December 2020

The Expert Consensus Guideline Series. Treatment of depression in women.

1 reference

12 December 2020

Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries

1 reference

12 December 2020

Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria

1 reference

12 December 2020

Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria

1 reference

12 December 2020

Chronobiological basis of female-specific mood disorders

1 reference

12 December 2020

Premenstrual syndrome: documentation by a linear analog scale compared with two descriptive scales

1 reference

12 December 2020

Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder

1 reference

12 December 2020

Fluoxetine in the treatment of late luteal phase dysphoric disorder

1 reference

12 December 2020

Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder

1 reference

12 December 2020

d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression.

1 reference

12 December 2020

Open trial of fluoxetine therapy for premenstrual syndrome

1 reference

12 December 2020

Nefazodone in the treatment of premenstrual syndrome: a preliminary study

1 reference

12 December 2020

Venlafaxine in the treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

Reliability and validity of a daily diary for premenstrual syndrome.

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual dysphoria

1 reference

12 December 2020

[Premenstrual dysphoric disorder: long-term treatment with fluoxetine and discontinuation]

1 reference

12 December 2020

Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability?

1 reference

12 December 2020

The role of fluoxetine in the treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome.

1 reference

12 December 2020

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Altered serotonergic activity in women with dysphoric premenstrual syndromes

1 reference

12 December 2020

Paroxetine as a treatment for premenstrual dysphoric disorder

1 reference

12 December 2020

A double-blind trial of four medications to treat severe premenstrual syndrome

1 reference

12 December 2020

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

1 reference

12 December 2020

Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo

1 reference

12 December 2020

Fluoxetine's spectrum of action in premenstrual syndrome.

1 reference

12 December 2020

Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?

1 reference

12 December 2020

The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications

1 reference

12 December 2020

Buspirone in treatment of premenstrual syndrome

1 reference

12 December 2020

Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

Effect of clomipramine on premenstrual syndrome

1 reference

12 December 2020

Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Premenstrual syndrome, neuroactive steroids and the brain

1 reference

12 December 2020

Single-dose fluoxetine in management of premenstrual syndrome

1 reference

12 December 2020

10.2165/00003495-200262130-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1009500662

0 references

1 reference